Evidence map›Paper›PMID 25556058›Full record

ArticleExperimental cell research2015

The natural tumorcide Manumycin-A targets protein phosphatase 1α and reduces hydrogen peroxide to induce lymphoma apoptosis.

Gregory B Carey, Sanjit K Roy, Hanako Daino

Open access · greenAbstract read
In one paragraph

Article in Experimental cell research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Effectors of thioredoxin reductase: Brevetoxins and manumycin-A.Comparative biochemistry and physiology. Toxicology & pharmacology : CBP · 2019
    Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Gregory B CareyDepartment of Microbiology and Immunology, University of Maryland, Baltimore, MD 21201, United States; Program in Oncology, Marlene and Stewart Greenebaum Cancer Center, University of Maryland, Baltimore, MD 21201, United States; Center for Vascular and Inflammatory Diseases, University of Maryland, Baltimore, MD 21201, United States. Electronic address: Gcarey@som.umaryland.edu.
Sanjit K RoyDepartment of Microbiology and Immunology, University of Maryland, Baltimore, MD 21201, United States; Center for Vascular and Inflammatory Diseases, University of Maryland, Baltimore, MD 21201, United States.
Hanako DainoCenter for Vascular and Inflammatory Diseases, University of Maryland, Baltimore, MD 21201, United States.
University of Maryland, Baltimore · US

Funding

mIgM and mIgD Receptor Signaling in B Lymphoma ApoptosisK01CA094027 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI CAREY, GREGORY B · 2002 to 2006
$692k
Role of Reactive Oxygen Species in B Lymphoma FateUH2CA158689 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI CAREY, GREGORY B · 2011 to 2012
$355k
NCI NIH HHS CA-94027CA-122882NCI NIH HHS K01 CA094027NCI NIH HHS UH2 CA158689NCI NIH HHS UH2CA-158689
6 · The paper itself

Abstract

Numerous compounds for treating human disease have been discovered in nature. Manumycin-A (Man-A) is a natural, well-tolerated microbial metabolite and a potent experimental tumoricide. We recently showed that Man-A stimulated reactive oxygen species (ROS) which were upstream of serine/threonine (Ser/Thr) dephosphorylation and caspase-dependent cleavage of MEK and Akt in lymphoma apoptosis. Conversely, activation-specific, Ser/Thr phosphorylation of MEK and Akt proteins was stable in Man-A-resistant tumors suggesting that stimulation of Ser/Thr PPase activity might be required for Man-A tumoricidal activity. Pre-treatment with Calyculin-A, an equipotent inhibitor of PP1 and PP2A, blocked all downstream effects of Man-A whereas, the PP2A-selective inhibitor, Okadaic acid did not, suggesting that PP1 and not PP2A played a role in Man-A action. Phosphorylation of PP1α on Thr320 inhibits its activity. Hence, we posited that if PP1α was important for Man-A action, then Man-A treatment should promote dephosphorylation of PP1α on Thr320. Indeed, T320 was only dephosphorylated in the tumors that underwent apoptosis. Lastly, stable over-expression of a constitutively active PP1α mimetic (PP1αT320A mutant), elevated basal ROS levels and enhanced Man-A-stimulated apoptosis. Taken together, we conclude that PP1α is an important proximal effector of Man-A mediated lymphoma apoptosis and that the mechanisms of Man-A action warrant further investigation.

Indexed as

AnimalsAntineoplastic AgentsApoptosisHumansHydrogen PeroxideJurkat CellsK562 CellsLymphomaMAP Kinase Kinase KinasesMarine ToxinsMembrane Potential, MitochondrialMiceOxazolesPhosphorylationPolyenesPolyunsaturated AlkamidesAntineoplastic Agentscalyculin AHydrogen PeroxidemanumycinMAP Kinase Kinase KinasesMarine ToxinsOxazolesPolyenesPolyunsaturated AlkamidesProtein Phosphatase 1Proto-Oncogene Proteins c-aktVanadatesAktApoptosisHydrogen peroxideLymphomaManumycin-AMEKNatural tumoricideProtein phosphatase 1α, PP1αReactive oxygen speciesSuperoxide

Identifiers

PMID25556058
PMCPMC9976551
OpenAlexW2080922866

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.